Addex Therapeutics (ADXN) Other Operating Expenses (2022 - 2024)
Historic Other Operating Expenses for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to $7.5 million.
- Addex Therapeutics' Other Operating Expenses fell 894.52% to $7.5 million in Q4 2024 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year decrease of 894.52%. This contributed to the annual value of -$219040.1 for FY2024, which is 157395.52% down from last year.
- Addex Therapeutics' Other Operating Expenses amounted to $7.5 million in Q4 2024, which was down 894.52% from $8.2 million recorded in Q4 2023.
- Over the past 5 years, Addex Therapeutics' Other Operating Expenses peaked at $17.3 million during Q4 2022, and registered a low of -$0.0 during Q1 2022.
- Over the past 3 years, Addex Therapeutics' median Other Operating Expenses value was $3.7 million (recorded in 2023), while the average stood at $5.5 million.
- Examining YoY changes over the last 5 years, Addex Therapeutics' Other Operating Expenses showed a top increase of 7500.0% in 2023 and a maximum decrease of 5242.99% in 2023.
- Addex Therapeutics' Other Operating Expenses (Quarter) stood at $17.3 million in 2022, then plummeted by 52.43% to $8.2 million in 2023, then fell by 8.95% to $7.5 million in 2024.
- Its Other Operating Expenses stands at $7.5 million for Q4 2024, versus $8.2 million for Q4 2023 and -$0.0 for Q2 2023.